Wecome to WEED inc.

Cannabis & Hemp Subsidiary

WEED, Inc.

Cannabis & Hemp Subsidiary

WEED, Inc. is a multi-national, multi-faceted, vertically integrated world-class cannabis organization led by President/CEO Glenn E. Martin.

WEED, Inc. is structured as a holding company doing business through its divisions,wholly-owned subsidiaries, and strategically placed collaborative partners to achieve and promote their global agenda and brand.

Sangre BioSciences is currently in the process of conducting a comprehensive Cannabis Genome Study to complete a global genomic classification of the cannabis plant genus. Sangre BioSciences is focused on a genomics based cannabis breeding program that will produce new, genetically enhanced strains of cannabis that express the desired plant characteristics for strain specific and disease specific treatments and therapies for both humans and animals.

WEED Australia Ltd.’s corporate strategy is to use its proprietary research, medical patents and clinical trials to create unique medical products and services for the treatment of human and animal diseases. Weed Australia Ltd. is assembling a highly qualified team of well respected PhD’s, scientists, researchers and business experts to reach it goals of establishing a strong domestic distribution market along with robust international export channels.

WEED Israel Cannabis Ltd. was established to build and expand WEED, Inc.’s global presence. In support of WEED Israel Cannabis Ltd., WEED, Inc. has entered into an exclusive license and assignment agreement with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Israel. The agreement is for five patents, technology and know-how relating to formulations for the administration and delivery of cannabinoid compounds. These patents were developed by Prof. Elka Touitou at the Hebrew University of Jerusalem. Human clinical trials using these five patents, technology, research and know-how are anticipated to commence in the 3rd quarter 2019. WEED Israel Cannabis Ltd. is currently obtaining licenses to grow, cultivate, process, extract, and manufacture cannabis based products for the Israeli domestic and broader international markets.

The Hemp Institute of Arizona was established by WEED, Inc. to research and study the hemp plant, both industrial and CBD strains, to create forward-looking cultivation techniques and to find new methods of extracting CBD compounds for use in medical applications. The Hemp Institute of Arizona is the non-profit arm of WEED, Inc.’s American domestic operation with the goal of advancing the scientific mission of the company.

The Cannabis Institute of Australia was formed by WEED Australia Ltd. as its nonprofit division in March 2018 with the goal of creating a scientific advisory council to establish national protocols and procedures backed by scientific research.

With its network of Ph.D.'s and doctors across Australia, The Cannabis Institute of Australia hopes to perfect strain specific, disease-specific treatments, therapies and cures for both humans and animals. The Cannabis Institute of Australia will educate and oversee clinical trials, protocols, and procedures for both humans & animals, medical discoveries & products to conquer the opioid addiction with natural remedies. Educating MD's & naturopathic doctors is key to implementing a national cannabis medical program.